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Abstract 
The case presented raised our scientific curiosity and it is worthy of being brought in front of the medical audience because 
of several reasons presented below.   
Presently, there are 3 hereditary syndromes that have a demonstrated etiological relationship with the colorectal cancer: Familiar 
Adenomatous Polyposis (FAP syndrome), HNPCC syndrome (Hereditary Nonpoliposis Colorectal Cancer) and MAP syndrome. 
Discovered only in 2002, the MAP syndrome (MYH associated polyposis) is the first hereditary syndrome that has 
autosomal recessive transmission.  
The APC gene can be mutated in several ways during the colonic oncogenesis: congenital in the FAP syndrome, somatic 
in sporadic colorectal cancers and secondary to the MYH gene inactivation in MAP syndrome. 
MAP phenotype is similar to the FAP phenotype because of the somatic mutations to the APC gene.  
Colonic polyposis is lower than FAP syndrome and appeared later, in the 40’s and 50’s. Colorectal cancers are frequent and 
discovered in the same moment as the colonic polyposis.  
Patients are diagnosed mostly in cancer stages. Colonoscopy shows polyps disseminated around the entire colic frame. 
Treatment in these cases is total rectocolectomy with ileoanal anastomosis.  
When working in a general emergency surgery clinic, physicians are often faced with colorectal cancers in different evolutive stages, 
and mostly they are faced with their complications. 
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Introduction 
Starting from the ever more increased frequency 
of the colorectal cancers, present conceptions over the 
oncological disease with this localisation, try to 
differentiate the varied levels of oncogenesis, all the way 
to the most profound, the genetic one. And so, genetic 
and epidemiological studies [2] have shown the existence 
of sporadic colorectal cancers, up to 90-95% [2] from the 
total colorectal cancers, out of which 30% [2] have familiar 
involvement without being able to establish a certain 
genetic layer, and hereditary cancers, 5-10% [2], to which 
the hereditary transmission mechanism has been 
demonstrated.  
Presently, there are 3 hereditary syndromes that 
have a demonstrated an etiological relationship with the 
colorectal cancer: Familiar Adenomatous Polyposis (FAP 
syndrome), HNPCC syndrome (Hereditary Nonpoliposis 
Colorectal Cancer) and MAP syndrome.[1],[2],[5] 
This paper tries to be a case report of a MAP 
syndrome defined on clinical criteria. This entity is 
interesting because of its extreme rarity and it has been 
defined and described for the first time in 2002.[2] So, we 
consider that a larger dispersal of the casuistic from this 
spectrum may lead to a better definition of this syndrome 
and may open new horizons for better knowledge of the 
genetic layer.  
Case report 
Patient aged 59, female, admitted in our clinic for 
descending colon cancer discovered during periodical 
colonoscopy revaluations. 
From the patient’s history: 
  The first episode of anal bleeding took place at 
the age of 44, in the year 1995; 
  At the age of 45, in 1996, the patient had a 
surgical intervention for bowl obstruction in 
another hospital. The post operatory diagnosis 
was superior rectal cancer. The attitude taken Journal of Medicine and Life Vol. 4, No. 1, January‐March 2011 
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was left ovary resection and 
rectosygmoidectomy with coloanal anastomosis 
and post operatory radiotherapy. A rectal 
stenosis, due to the radiotherapy, led to a difficult 
post operatory evolution.  
  At the age of 53, in 2004, the patient was 
urgently admitted in our clinic for bowl 
obstruction. The post operatory diagnosis was 
simultaneous transverse and descending colon. 
At that time, we chose large left hemicolectomy 
and left iliac anus.  
  At the age of 57, in 2007, having entered the 
post operatory colonoscopy follow-up, we 
discovered numerous colonic polyps that were 
treated by multiple endoscopic resections. Their 
presence raised the suspicion of colonic 
polyposis. This presence imposed total 
colectomy, which the patient refused at that time. 
  In this situation, the management had to be 
limited to colonoscopy follow-ups every 6 
months, having realised a real time survey of the 
succession polyp – polyposis – cancer. 
  In 2010, at the age of 59 years old, the patient 
was convinced to undergo surgery as the polyps 
from the cecum strongly suggested malignancy 
transformation. Completion of the colectomy 
(total rectocolectomy) was chosen as the correct 
therapeutic choice.  
From the personal pathological history of the 
patient, it is worth mentioning an acute colecistitis – 
colecistectomy at the age 29, bilateral renal lithiasis, 
hepatic steatosis and multiple acute pancreatitis.    
From her family history we found out that she 
had two brothers, the first was diagnosed with colonic 
polyposis at the age 49 when total colectomy with ileo-
rectal anastomosis was done (MAP syndrome?), and the 
other was diagnosed with colonic polyposis and Hodgkin 
lymphoma at the age of 62, both of them deceased.  
Discussions 
Genetics 
Discovered only in 2002, the MAP syndrome 
(MYH associated polyposis) is the first hereditary 
syndrome that has autosomal recessive transmission. It 
has almost complete penetration and variable expression. 
There is no subsequent mutation because the two alleles 
are mutated from birth. [2] 
The MYH gene from chromosome 1 locus lp34, 
along with other genes, belongs to the DNA repairing 
system called „Base Excision Repair” (BER). If this 
system is inactivated by bi-allelic mutations, several 
somatic mutations will have taken place, especially on the 
APC gene (Adenomatous Polyposis Coli). These somatic 
mutations on the APC gene explain the similar phenotype 
found also in the Familiar Adenomatous Polyposis 
syndrome (FAP). [2] 
It is imperative to look for a MYH gene mutation 
when faced with a patient with colonic polyposis and a 
germinal mutation identified on APC gene. [1] 
In addition, there is a different family history: the 
MAP syndrome is transmitted in a recessive manner – 
there is no vertical case history, the parents are 
heterozygous and so healthy. The transmitting risk of the 
disease is 25% for the MAP syndrome and 50% for the 
FAP syndrome in which the transmitting is dominant. [3] 
A patient with a clinical manifest MAP syndrome has a 
risk of transmitting the disease to its descendents of 
under 1%. Therefore, the prevalence of heterozygote 
mutation on MYH gene is around 1%. [5] 
The APC gene can be mutated in several ways 
during the colonic oncogenesis: congenital in the FAP 
syndrome, somatic in sporadic colorectal cancers and 
secondary to the MYH gene inactivation in MAP 
syndrome. [2] 
 
Clinical and diagnostic aspects 
MAP phenotype is similar to the FAP phenotype 
because of the somatic mutations to the APC gene. [4] 
Colonic polyposis is lower than FAP syndrome and 
appeared later, in the 40’s and 50’s. Colorectal cancers 
are frequent and discovered at the same moment as the 
colonic polyposis. This is partially explained by the fact 
that the parents are healthy and so there is no method for 
discovering the cancer. [2] 
Extra-colonic symptoms are less frequent than in 
the FAP syndrome. Gastric and duodenal manifestations 
(duodenal and gastric polyps) are the most frequent which 
are discovered. No desmoids tumours have been found 
until this moment, related to the MAP syndrome.[2] Until 
now, the diagnosis has been based entirely on the 
complex sequencing of MYH gene on the circulatory 
lymphocytes DNA. [2] 
 
Management of patients with MAP syndrome 
Patients are diagnosed mostly in cancer 
stages.[4] Colonoscopy shows polyps disseminated 
around the entire colic frame. Treatment in these cases is 
total rectocolectomy with ileoanal anastomosis.[2] 
For patients who during a genetic screening test 
have been found with MYH gene mutations, surveillance 
must be completed by annual colonoscopy starting at the 
age 20 and biannual eso-gastro-duodeno endoscopy for 
extracolonic involvement.[2] 
When polyps become too numerous, prophylactic surgery 
is imposed. The elective intervention is total 
rectocolectomy with ileoanal anastomosis. If the rectum is 
intact, it is possible to conserve it and realize a total 
colectomy with ileorectal anastomosis. Annual 
surveillance by rectoscopy is imposed in these cases.[5] Journal of Medicine and Life Vol. 4, No. 1, January‐March 2011 
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Personal opinions 
The MAP syndrome diagnose is often made 
rather late, towards the age of 50, because of the rarity 
and difficulty to proper predict or etiologically and 
pathogenically border this entity. The starting point of this 
diagnose is a constituted colonic adenocarcinoma, with or 
without concomitant colonic polyps of various dimensions.  
Clinical criteria impose a differentiation between the MAP 
syndrome and the HNPCC syndrome if the 
adenocarcinoma is not accompanied by colonic polyposis. 
Moreover, the genetic mechanism is essentially 
the same – the anomaly of a DNA repairing system (BER 
– Buzz Excision Repair in the MAP syndrome or MMR – 
MisMatch Repair in HNPCC syndrome).  
Finding colonic polyposis on colonoscopy, at an 
individual older than 40, must alienate the clinician from 
any suspicion of FAP syndrome, which is a more well 
known and frequent entity, in which malignancy is almost 
complete at the age of 30. 
Complete sequencing of APC gene belonging to 
the chromosome 5 from the circulatory lymphocytes is 
now the consecrated genetic test for the FAP syndrome. 
Faced with a patient with colonic polyposis, but without 
APC gene mutation, we must search for the MYH gene 
mutation belonging to chromosome 1 from the circulatory 
lymphocytes. 
Besides, personal and familiar history differs 
essentially. In MAP syndrome there is no vertical 
continuity because the transmission is autosomal 
recessive and so, the parents are heterozygote and 
healthy. 
The risk of transmitting this disease to its 
descendent is less than 1%. 
Working in a general emergency surgery clinic, 
we are often faced with colorectal cancers in different 
evolutive stages, and mostly we are faced with their 
complications. 
This case raised our scientific curiosity and so 
we found it worthy of being brought in front of the medical 
audience because of the following reasons:   
-  Appearance of a second colonic cancer after 8 
years from the first diagnosis; 
-  The lack of colonic polyposis at the moment of 
the first diagnosis and its presence after almost 
11 years; 
-  Because of the patient rejection to the total 
colectomy, we were forced to watch the 
evolution of these polyps all the way to their 
malignancy. 
-  The number and aspect of these polyps 
excluded both the typical FAP syndrome aspect 
(“polyp’s carpet”) and the sporadic adenomatosic 
polyp that is a predecessor for most colorectal 
cancers.  
-  On the other hand, the age of the patient placed 
her between the two entities described before, 
the young age from FAP syndrome and the age 
over 50 from the colonic sporadic cancer.  
-  The two first-degree relatives diagnosed around 
the age 50 with colonic cancer preceded by 
colonic polyposis weighted also in the evocation 
of this probable diagnostic.  
-  As practitioners, we considered justified to raise 
the problem of etiological, pathogenic and even 
genetic context of a colorectal cancer at a 
middle-aged patient, when at this age the 
frequency of this disease is so rare. 
-  We have not had available data on the initial 
explorations of the colon (pan-colonoscopy) so 
that we could state the undisputed absence of 
the colonic polyps at that time, besides the 
explored colon during surgery. In the post-
operatory period, this investigation was 
impossible due to a post-radiotherapy rectal 
stenosis.   
-  Our first surgical intervention had an emergency 
character due to an occlusive complication, and 
so the colonoscopic investigation was yet 
delayed for another period of time. 
We consider extremely important to apply the 
rule of the three moments in which you must have a pan-
colonoscopy: in the pre-operatory period, during surgery 
or in the first 6 months post-operatory.  
In conclusion, diagnose is easy when you think 
of it. However, to think of such a syndrome you must have 
clues that will orientate ulterior diagnostic sequences – 
endoscopy, genetic testing. 
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